Our experience with immune checkpoint inhibitors in triple-negative breast cancer patients

被引:0
|
作者
Nishio, Minako [1 ]
Kojitani, Yoshiki [1 ]
Kitashiro, Saya [1 ]
Ishiduka, Yasunobu [1 ]
Otsuka, Tomoyuki [1 ]
Nishida, Naohiro [1 ]
Fujisawa, Fumie [1 ]
Sugimoto, Naotoshi [1 ]
Yagi, Toshinari [1 ]
Souma, Ai [2 ]
Kanaoka, Haruka [2 ]
Oyamayama, Yuri [2 ]
Taniguchi, Azusa [2 ]
Nakajima, Satomi [2 ]
Seto, Yukiko [2 ]
Kusama, Hiroki [2 ]
Watanabe, Noriyuki [2 ]
Matsui, Saki [2 ]
Nakayama, Takahiro [2 ]
Kudou, Toshihiro [1 ]
机构
[1] Osaka Int Canc Inst, Osaka Prefectural Hosp Org, Dept Med Oncol, Osaka, Japan
[2] Osaka Int Canc Inst, Osaka Prefectural Hosp Org, Dept Breast Surg, Osaka, Japan
关键词
D O I
10.1016/j.annonc.2023.09.3098
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P67-5
引用
收藏
页码:S1465 / S1465
页数:1
相关论文
共 50 条
  • [11] Immune checkpoint inhibitors for triple-negative breast cancer: From immunological mechanisms to clinical evidence
    Farshbafnadi, Melina
    Khoshbin, Amin Pastaki
    Rezaei, Nima
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 98
  • [12] A real-world study of immune checkpoint inhibitors in advanced triple-negative breast cancer
    Zhang, Zheng
    Zhang, Yadi
    Liu, Chuanling
    Shao, Jiakang
    Chen, Yimeng
    Zhu, Yimin
    Zhang, Li
    Qin, Boyu
    Kong, Ziqing
    Wang, Xixi
    Wang, Yutong
    Huang, Deqin
    Liu, Liqun
    Zhou, Yuxin
    Tao, Ran
    Yang, Zengjie
    Liu, Mei
    Zhao, Weihong
    CANCER INNOVATION, 2023, 2 (03): : 172 - 180
  • [13] VISTA immune checkpoint deregulation in human triple-negative breast cancer
    Gruber, Joshua J.
    Juntilla, Marisa M.
    Yang, Soo-Ryum
    Geller, Benjamin
    Jager, Natalie
    Lin, Chien-Yu
    Lipchik, Andrew M.
    Chen, Justin
    Ram, Ashwin
    Vinayak, Shaveta
    Telli, Melinda L.
    West, Robert B.
    Ford, James M.
    Snyder, Michael P.
    CANCER RESEARCH, 2018, 78 (13)
  • [14] Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer
    Isaacs, James
    Anders, Carey
    McArthur, Heather
    Force, Jeremy
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (05)
  • [15] Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer
    James Isaacs
    Carey Anders
    Heather McArthur
    Jeremy Force
    Current Treatment Options in Oncology, 2021, 22
  • [16] Positive progress: current and evolving role of immune checkpoint inhibitors in metastatic triple-negative breast cancer
    Simmons, Christine E.
    Brezden-Masley, Christine
    McCarthy, Joy
    McLeod, Deanna
    Joy, Anil Abraham
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [17] Immune checkpoint inhibitors for triple-negative inflammatory breast cancer (INCORPORATE): an international multicenter retrospective analysis
    Valenza, Carmine
    Trapani, Dario
    Zagami, Paola
    Antonarelli, Gabriele
    Bielo, Luca Boscolo
    Nicolo, Eleonora
    Ribeiro, Joana Mourato
    Guidi, Lorenzo
    Reduzzi, Carolina
    Spotti, Martina
    Munzone, Elisabetta
    Cortes, Javier
    Pistilli, Barbara
    Tolaney, Sara
    Ueno, Naoto
    Layman, Rachel
    Cristofanilli, Massimo
    Carey, Lisa
    Lynce, Filipa
    Woodward, Wendy
    Curigliano, Giuseppe
    CANCER RESEARCH, 2024, 84 (09)
  • [18] Use of Immune Checkpoint Inhibitors in Early Triple-Negative Breast Cancer: Beyond the Early Conflicting Results
    Din, Mohammad Ammad Ud
    Jamshed, Saad
    Patel, Mehul
    CLINICAL BREAST CANCER, 2021, 21 (03) : 153 - 155
  • [19] Epigenetic Repression of STING by MYC Promotes Immune Evasion and Resistance to Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer
    Lee, Kyung-min
    Lin, Chang-Ching
    Servetto, Alberto
    Bae, Joonbeom
    Kandagatla, Vishal
    Ye, Dan
    Kim, GunMin
    Sudhan, Dhivya R.
    Mendiratta, Saurabh
    Ericsson, Paula I. Gonzalez
    Balko, Justin M.
    Lee, Jeon
    Barnes, Spencer
    Malladi, Venkat S.
    Tabrizi, Siamak
    Reddy, Sangeetha M.
    Yum, Seoyun
    Chang, Ching-Wei
    Hutchinson, Katherine E.
    Yost, Susan E.
    Yuan, Yuan
    Chen, Zhijian J.
    Fu, Yang-Xin
    Hanker, Ariella B.
    Arteaga, Carlos L.
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (07) : 829 - 843
  • [20] Immune checkpoint inhibition in early-stage triple-negative breast cancer
    Varma, Revati
    Wright, Matthew
    Abraham, Jame
    Kruse, Megan
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (11) : 1225 - 1238